Video Experimental Relacionado
Updated: Sep 10, 2025
07:35
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
11.6K
Enfermedad renal mediada: una revisión y una mirada hacia el futuro
Vinay Srinivasan1, Paolo Nikolai So2, Edward P K Kwakyi3
1Division of Nephrology, Cooper University Hospital and Cooper Medical School of Rowan University, Camden, NJ.
Kidney medicine
|August 21, 2025
Resumen
Los factores genéticos como los alelos de riesgo APOL1 contribuyen a las disparidades de enfermedad renal en las personas de ascendencia africana. Comprender estos vínculos genéticos y los desencadenantes potenciales es clave para desarrollar tratamientos dirigidos y estrategias de pruebas genéticas.
Área de la Ciencia:
- Nefrología
- La genética
- Epidemiología
Sus antecedentes:
- Las personas de ascendencia africana reciente experimentan tasas desproporcionadamente altas de enfermedad renal.
- El descubrimiento de alelos de riesgo del gen Apolipoproteína L1 (APOL1) (G1 y G2) ofrece información sobre estas disparidades de salud.
- Los alelos de alto riesgo de APOL1 pueden proporcionar protección evolutiva contra los parásitos Trypanosoma, pero están relacionados con la enfermedad renal en ciertas poblaciones.
Objetivo del estudio:
- Revisar el desarrollo y las implicaciones clínicas de los alelos de riesgo APOL1 en la enfermedad renal.
- Para discutir la hipótesis del "segundo golpe" que involucra factores genéticos, ambientales y inflamatorios.
- Proponer un marco para los nefrólogos con respecto a las pruebas genéticas de APOL1.
Principales métodos:
- Revisión de la literatura científica sobre el gen APOL1, los alelos de riesgo y la enfermedad renal.
- Discusión de los mecanismos de toxicidad celular y objetivos terapéuticos.
- Análisis de los datos de ensayos clínicos, incluida la progresión de inaxaplin a la Fase 3.
Principales resultados:
- Aproximadamente 6 millones de afroamericanos poseen un genotipo APOL1 de alto riesgo.
- No todas las personas con genotipos de alto riesgo desarrollan enfermedad renal, lo que sugiere factores contribuyentes adicionales.
- Se están investigando terapias dirigidas como la inaxaplina para la enfermedad renal asociada con APOL1.
Conclusiones:
- Los alelos de riesgo APOL1 contribuyen significativamente a las disparidades en la enfermedad renal.
- Es crucial realizar más investigaciones sobre los desencadenantes genéticos, ambientales y inflamatorios.
- Las pruebas genéticas accesibles y las terapias dirigidas son prometedoras para el manejo de la enfermedad renal relacionada con APOL1.
Videos de Conceptos Relacionados
01:28Chronic Kidney Disease III: Interprofessional Care
78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:25Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
01:29Acute Kidney Injury II: Pathophysiology
72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
01:20Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60